Cutting edge: the HLA-A*0101-restricted HY minor histocompatibility antigen originates from DFFRY and contains a cysteinylated cysteine residue as identified by a novel mass spectrometric technique - PubMed (original) (raw)
. 1999 Dec 15;163(12):6360-4.
E D Field, J M den Haan, J A Caldwell, F M White, J A Marto, W Wang, L M Frost, E Blokland, C Reinhardus, J Shabanowitz, D F Hunt, E Goulmy, V H Engelhard
Affiliations
- PMID: 10586024
Cutting edge: the HLA-A*0101-restricted HY minor histocompatibility antigen originates from DFFRY and contains a cysteinylated cysteine residue as identified by a novel mass spectrometric technique
R A Pierce et al. J Immunol. 1999.
Abstract
In this report, we describe the use of novel mass spectrometry instrumentation to identify a male-specific minor histocompatibility Ag restricted by HLA-A*0101 (A1-HY). This Ag has the sequence IVDC*LTEMY, where C* represents a cysteine disulfide bonded to a second cysteine residue. The core peptide sequence is found in the protein product of DFFRY, a Y chromosome gene not previously identified as the source of an HY Ag. The male-specific form of the peptide differs from its X chromosomal counterpart by the substitution of serine for the C* residue. Both peptides are expressed on the cell surface at 30 or fewer copies per cell. However, A1-HY-specific CTL recognize the DFFRY-derived peptide at a 1500-fold lower dose than the female homologue. Thus, these studies have identified a new source of HY epitopes and provide additional information about the influence of posttranslational modifications of class I-associated peptides on T cell recognition.
Similar articles
- Expansion and activation of minor histocompatibility antigen HY-specific T cells associated with graft-versus-leukemia response.
Takami A, Sugimori C, Feng X, Yachie A, Kondo Y, Nishimura R, Kuzushima K, Kotani T, Asakura H, Shiobara S, Nakao S. Takami A, et al. Bone Marrow Transplant. 2004 Oct;34(8):703-9. doi: 10.1038/sj.bmt.1704583. Bone Marrow Transplant. 2004. PMID: 15322566 - Novel HY peptide antigens presented by HLA-B27.
Simmons WA, Summerfield SG, Roopenian DC, Slaughter CA, Zuberi AR, Gaskell SJ, Bordoli RS, Hoyes J, Moomaw CR, Colbert RA, Leong LY, Butcher GW, Hammer RE, Taurog JD. Simmons WA, et al. J Immunol. 1997 Sep 15;159(6):2750-9. J Immunol. 1997. PMID: 9300696 Retracted. - The human cathepsin H gene encodes two novel minor histocompatibility antigen epitopes restricted by HLA-A*3101 and -A*3303.
Torikai H, Akatsuka Y, Miyazaki M, Tsujimura A, Yatabe Y, Kawase T, Nakao Y, Tsujimura K, Motoyoshi K, Morishima Y, Kodera Y, Kuzushima K, Takahashi T. Torikai H, et al. Br J Haematol. 2006 Aug;134(4):406-16. doi: 10.1111/j.1365-2141.2006.06205.x. Epub 2006 Jul 4. Br J Haematol. 2006. PMID: 16822283 - Minor histocompatibility antigen DDX3Y induces HLA-DQ5-restricted T cell responses with limited TCR-Vbeta usage both in vivo and in vitro.
Laurin D, Spierings E, van der Veken LT, Hamrouni A, Falkenburg JH, Souillet G, Vermeulen C, Farre A, Galambrun C, Rigal D, Bertrand Y, Goulmy E, Eljaafari A. Laurin D, et al. Biol Blood Marrow Transplant. 2006 Nov;12(11):1114-24. doi: 10.1016/j.bbmt.2006.07.012. Biol Blood Marrow Transplant. 2006. PMID: 17085304 - Bi-directional allelic recognition of the human minor histocompatibility antigen HB-1 by cytotoxic T lymphocytes.
Dolstra H, de Rijke B, Fredrix H, Balas A, Maas F, Scherpen F, Aviles MJ, Vicario JL, Beekman NJ, Ossendorp F, de Witte TM, van de Wiel-van Kemenade E. Dolstra H, et al. Eur J Immunol. 2002 Oct;32(10):2748-58. doi: 10.1002/1521-4141(2002010)32:10<2748::AID-IMMU2748>3.0.CO;2-T. Eur J Immunol. 2002. PMID: 12355426
Cited by
- Interferon-α promotes neo-antigen formation and preferential HLA-B-restricted antigen presentation in pancreatic β-cells.
Carré A, Zhou Z, Perez-Hernandez J, Samassa F, Lekka C, Manganaro A, Oshima M, Liao H, Parker R, Nicastri A, Brandao B, Colli ML, Eizirik DL, Göransson M, Morales OB, Anderson A, Landry L, Kobaisi F, Scharfmann R, Marselli L, Marchetti P, You S, Nakayama M, Hadrup SR, Kent SC, Richardson SJ, Ternette N, Mallone R. Carré A, et al. bioRxiv [Preprint]. 2023 Sep 17:2023.09.15.557918. doi: 10.1101/2023.09.15.557918. bioRxiv. 2023. PMID: 37745505 Free PMC article. Preprint. - The Effects of Donor-Recipient Age and Sex Compatibility in the Outcomes of Deep Anterior Lamellar Keratoplasties.
Ong HS, Chiam N, Htoon HM, Kumar A, Arundhati A, Mehta JS. Ong HS, et al. Front Med (Lausanne). 2022 Jan 27;8:801472. doi: 10.3389/fmed.2021.801472. eCollection 2021. Front Med (Lausanne). 2022. PMID: 35155480 Free PMC article. - Gender medicine in corneal transplantation: influence of sex mismatch on rejection episodes and graft survival in a prospective cohort of patients.
Fasolo A, Gallon P, Frigo AC, Birattari F, Monterosso C, Rapizzi E, Brighenti T, Pedrotti E, Marro C, Viola P, Ponzin D, Franch A. Fasolo A, et al. Cell Tissue Bank. 2021 Mar;22(1):47-56. doi: 10.1007/s10561-020-09864-x. Epub 2020 Sep 15. Cell Tissue Bank. 2021. PMID: 32935191 Clinical Trial. - Impact of Cysteine Residues on MHC Binding Predictions and Recognition by Tumor-Reactive T Cells.
Sachs A, Moore E, Kosaloglu-Yalcin Z, Peters B, Sidney J, Rosenberg SA, Robbins PF, Sette A. Sachs A, et al. J Immunol. 2020 Jul 15;205(2):539-549. doi: 10.4049/jimmunol.1901173. Epub 2020 Jun 22. J Immunol. 2020. PMID: 32571843 Free PMC article. - Two Distinct Conformations in Bet v 2 Determine Its Proteolytic Resistance to Cathepsin S.
Soh WT, Briza P, Dall E, Asam C, Schubert M, Huber S, Aglas L, Bohle B, Ferreira F, Brandstetter H. Soh WT, et al. Int J Mol Sci. 2017 Oct 16;18(10):2156. doi: 10.3390/ijms18102156. Int J Mol Sci. 2017. PMID: 29035299 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Molecular Biology Databases
Research Materials